<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03855267</url>
  </required_header>
  <id_info>
    <org_study_id>GWang007</org_study_id>
    <nct_id>NCT03855267</nct_id>
  </id_info>
  <brief_title>Etomidate/Propofol Mixture or Propofol Monotherapy Use in Patients Undergoing General Anesthesia</brief_title>
  <official_title>Effects of Etomidate/Propofol Mixture or Propofol Monotherapy With Different Proportions on Circulation and Prognosis in Patients Undergoing General Anesthesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Guolin Wang</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tianjin Medical University General Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study was to investigate the effects of different proportions of
      etomidate/propofol mixture and propofol alone intravenous anesthesia on intraoperative and
      postoperative physiological indicators and complications, and to find out the optimal use
      ratio of E/P mixture.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Propofol is one of the most commonly used intravenous anesthesia drugs clinically, the
      pharmacokinetic characteristics makes it very suitable for total intravenous anesthesia(
      TIVA), etomidate belongs to intravenous anesthesia with propofol, is a derivative of the
      imidazoles, its calm performance is strong, work quickly, no obvious respiratory depression,
      had little effects on the cardiovascular system, which, therefore, to protect the
      cardiovascular, maintain hemodynamic stability has a certain advantage. Our previous project
      showed that propofol and etomidate combined application can maintain stable hemodynamics in
      patients with better, reduce the occurrence of adverse reactions, can be used within 3 h of
      surgery anesthesia.The purpose of this study is to use propofol or etomidate/propofol mixture
      in combination with BIS monitoring to perform general anesthesia maintenance for patients, in
      order to ensure the appropriate depth of anesthesia, better maintain the hemodynamic
      stability of patients, reduce adverse reactions, and find the appropriate E/P mixture of the
      best proportion and dose.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2019</start_date>
  <completion_date type="Anticipated">December 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>blood pressure</measure>
    <time_frame>intraoperative</time_frame>
    <description>the blood pressure is recorded (mmHg)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>heart rate</measure>
    <time_frame>intraoperative</time_frame>
    <description>the heart rate is recorded(bpm)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Perioperative complications</measure>
    <time_frame>intraoperative</time_frame>
    <description>the incidence of injection pain #nausea and vomit#intraoperative awareness and postoperative agitation.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Recovery time</measure>
    <time_frame>intraoperative</time_frame>
    <description>Anesthesia awakening time and extubation time</description>
  </other_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Etomidate is Mixed With Propofol</condition>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Propofol 20 mg/ml, recommended anesthesia induction dose of 0.1~0.125 ml/kg, anesthesia maintenance pump speed of 0.2~0.5ml/kg/h. keep bispectral index within 40 # 60</description>
  </arm_group>
  <arm_group>
    <arm_group_label>GroupB</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>EP1:3, that is, 10ml etomidate was mixed with 30ml propofol, the recommended anesthesia induction dose was 0.1-0.125ml /kg, and the anesthesia maintenance pump speed was 0.2-0.5ml /kg/h.keep bispectral index within 40 # 60.Propofol 20 mg/ml,etomidate 2mg/ml.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group C</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>EP1:1, that is, 20ml etomidate was mixed with 20ml propofol, the recommended anesthesia induction dose was 0.1-0.125ml /kg, and the anesthesia maintenance pump speed was 0.2-0.5ml /kg/h.keep bispectral index within 40 # 60.Propofol 20 mg/ml,etomidate 2mg/ml.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group D</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>EP3:1, that is, 30ml etomidate was mixed with 10ml propofol, the recommended anesthesia induction dose was 0.1-0.125ml /kg, and the anesthesia maintenance pump speed was 0.2-0.5ml /kg/h.keep bispectral index within 40 # 60.Propofol 20 mg/ml,etomidate 2mg/ml.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol 20 MG/ML</intervention_name>
    <description>Pump propofol to keep bispectral index within 40 # 60</description>
    <arm_group_label>Group A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol 20 mg/ml , etomidate 2 mg/ml</intervention_name>
    <description>Propofol was mixed with etomidate in different proportions.keep bispectral index within 40 # 60.</description>
    <arm_group_label>Group C</arm_group_label>
    <arm_group_label>Group D</arm_group_label>
    <arm_group_label>GroupB</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients undergoing elective general anesthesia surgery in 3h;

          2. American Society of Anesthesiologists gradesâ… ~III;

          3. Aged 18 to 65 years, Body Mass Index 18.5 ~ 29.9kg / m2;

          4. Hemoglobin 100 ~ 125g / L.

          5. In line with the ethics, the patients volunteered to take the test and signed the
             informed consent

        Exclusion Criteria:

          1. Identify or suspect abuse or chronic use of narcotic sedatives and analgesics;

          2. Heart, or liver, or lung, or kidney dysfunction;

          3. Body mass index&gt; 30kg / m2; or &lt;18.5kg / m2

          4. Speech, hearing or mental disorders;

          5. severe diabetes, hyperkalemia ;

          6. participate in other drug clinical researches in four weeks;

          7. Poor compliance, can not complete clinical research by research program.

          8. Any cerebrovascular accident occurred within 3 months, such as stroke, TIA, etc

          9. Unstable angina and myocardial infarction occurred within 3 months;

         10. Having contraindications or allergies to experimental drugs and other narcotic drugs;

         11. Mental illness, hyperkalemia.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Guolin Wang, MD.PHD</last_name>
    <role>Study Director</role>
    <affiliation>Tainjin Medical University General Hospita</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Zicheng Wang, MM</last_name>
    <phone>13821112922</phone>
    <email>527640484@qq.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Zicheng Wang</name>
      <address>
        <city>Tianjin</city>
        <state>Tianjin</state>
        <zip>300000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zicheng wang, MM</last_name>
      <phone>13821112922</phone>
      <email>527640484@qq.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>February 2019</verification_date>
  <study_first_submitted>February 24, 2019</study_first_submitted>
  <study_first_submitted_qc>February 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 26, 2019</study_first_posted>
  <last_update_submitted>February 25, 2019</last_update_submitted>
  <last_update_submitted_qc>February 25, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">February 26, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Tianjin Medical University General Hospital</investigator_affiliation>
    <investigator_full_name>Guolin Wang</investigator_full_name>
    <investigator_title>Tianjin Medical University General Hospital</investigator_title>
  </responsible_party>
  <keyword>propofol</keyword>
  <keyword>etomidate</keyword>
  <keyword>General anesthesia</keyword>
  <keyword>mixture</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Etomidate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

